Literature DB >> 24105298

PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.

Pekka Määttänen1, Ryan Taschuk2, Li Ross3, Kristen Marciniuk4, Lisa Bertram3, Andrew Potter1, Neil R Cashman3, Scott Napper5.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative disorders caused by misfolding of a cellular protein PrP(C) into an infectious conformation PrP(Sc). Previously our group demonstrated induction of PrP(Sc)-specific antibodies with a SN6b vaccine that targets regions of the protein that are exposed upon misfolding. There are concerns that these antibodies could function as templates to promote misfolding and cause disease. To evaluate the consequences of prolonged exposure to PrP(Sc)-specific antibodies in a prion sensitized animal, tga20 mice were vaccinated with the SN6b vaccine. No clinical signs of disease were detected up to 255 d post-vaccination, and postmortem assay of brains and spleens revealed no proteinase-K resistant PrP. These results suggest that vaccinating against TSEs with the SN6b antigen is safe from the standpoint of prion disease induction.

Entities:  

Keywords:  disease specific epitope; immunotherapy; misfolding; prion; safety; vaccine

Mesh:

Substances:

Year:  2013        PMID: 24105298      PMCID: PMC4134347          DOI: 10.4161/pri.26639

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  28 in total

1.  Signal transduction through prion protein.

Authors:  S Mouillet-Richard; M Ermonval; C Chebassier; J L Laplanche; S Lehmann; J M Launay; O Kellermann
Journal:  Science       Date:  2000-09-15       Impact factor: 47.728

2.  Facilitated cross-species transmission of prions in extraneural tissue.

Authors:  Vincent Béringue; Laëtitia Herzog; Emilie Jaumain; Fabienne Reine; Pierre Sibille; Annick Le Dur; Jean-Luc Vilotte; Hubert Laude
Journal:  Science       Date:  2012-01-27       Impact factor: 47.728

3.  Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.

Authors:  Claudia A Madampage; Pekka Määttänen; Kristen Marciniuk; Robert Brownlie; Olga Andrievskaia; Andrew Potter; Neil R Cashman; Jeremy S Lee; Scott Napper
Journal:  Prion       Date:  2013-05-31       Impact factor: 3.931

4.  vCJD remains an enigma as UK deaths fall to zero for 2012.

Authors:  David Holmes
Journal:  Lancet Infect Dis       Date:  2012-12       Impact factor: 25.071

5.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.

Authors:  A R White; S J Collins; F Maher; M F Jobling; L R Stewart; J M Thyer; K Beyreuther; C L Masters; R Cappai
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.

Authors:  Tiziana Sonati; Regina R Reimann; Jeppe Falsig; Pravas Kumar Baral; Tracy O'Connor; Simone Hornemann; Sine Yaganoglu; Bei Li; Uli S Herrmann; Barbara Wieland; Mridula Swayampakula; Muhammad Hafizur Rahman; Dipankar Das; Nat Kav; Roland Riek; Pawel P Liberski; Michael N G James; Adriano Aguzzi
Journal:  Nature       Date:  2013-07-31       Impact factor: 49.962

Review 7.  Chronic wasting disease.

Authors:  Sabine Gilch; Nandini Chitoor; Yuzuru Taguchi; Melissa Stuart; Jean E Jewell; Hermann M Schätzl
Journal:  Top Curr Chem       Date:  2011

Review 8.  Prion disease: a tale of folds and strains.

Authors:  Hans Kretzschmar; Jörg Tatzelt
Journal:  Brain Pathol       Date:  2013-05       Impact factor: 6.508

Review 9.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

10.  Induction of ligand-specific PrP (C) signaling in human neuronal cells.

Authors:  Ryan J Arsenault; Yue Li; Andrew Potter; Philip J Griebel; Anthony Kusalik; Scott Napper
Journal:  Prion       Date:  2012-08-23       Impact factor: 3.931

View more
  3 in total

1.  In vitro neutralization of prions with PrP(Sc)-specific antibodies.

Authors:  Ryan Taschuk; Jacques Van der Merwe; Kristen Marciniuk; Andrew Potter; Neil Cashman; Philip Griebel; Scott Napper
Journal:  Prion       Date:  2015       Impact factor: 3.931

Review 2.  Prion diseases: immunotargets and therapy.

Authors:  Jennifer T Burchell; Peter K Panegyres
Journal:  Immunotargets Ther       Date:  2016-06-16

3.  A Progressive Loss of phosphoSer138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington's Disease: Possible Sex-Dependent Signaling.

Authors:  Akanksha Baharani; Zelan Wei; William J Roesler; Darrell D Mousseau
Journal:  Cell Mol Neurobiol       Date:  2020-10-27       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.